Dr. Scagliotti on the Future of Multiple Gene Profiles

Giorgio V. Scagliotti, MD, PhD
Published: Wednesday, Oct 12, 2011

Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, believes that in the near future it will be possible to systematically investigate multiple genes to establish the full role of a pathway in the tumor.

The DNA repair protein ERCC1 is being describes as a paradigm for the entire DNA repair process, Scagliotti explains, however, that a single gene is not ample to mirror the entire DNA repair mechanism. Examining the full profile of several genes will provide better information about how to treat the patients properly and their cytotoxic profiles.

Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, believes that in the near future it will be possible to systematically investigate multiple genes to establish the full role of a pathway in the tumor.

The DNA repair protein ERCC1 is being describes as a paradigm for the entire DNA repair process, Scagliotti explains, however, that a single gene is not ample to mirror the entire DNA repair mechanism. Examining the full profile of several genes will provide better information about how to treat the patients properly and their cytotoxic profiles.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x